<i>Orf Virus</i>-Based Vaccine Vector D1701-V Induces Strong CD8+ T Cell Response against the Transgene but Not against ORFV-Derived Epitopes by Alena Reguzova, Michael Ghosh, Melanie Müller, Hanns-Joachim Rziha, Ralf Amann

Get full text

A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept Study by Alena Reguzova, Nico Fischer, Melanie Müller, Ferdinand Salomon, Thomas Jaenisch, Ralf Amann

Get full text

A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2 by Alena Reguzova, Melanie Müller, Felix Pagallies, Dominique Burri, Ferdinand Salomon, Hanns-Joachim Rziha, Zsofia Bittner-Schrader, Babs E. Verstrepen, Kinga P. Böszörményi, Ernst J. Verschoor, Ingo Gerhauser, Knut Elbers, Meral Esen, Alessandro Manenti, Martina Monti, Hans-Georg Rammensee, Madiha Derouazi, Markus W. Löffler, Ralf Amann

Get full text

First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster by Meral Esen, Johanna Fischer-Herr, Julian Justin Gabor, Johanna Marika Gaile, Wim Alexander Fleischmann, Geerten Willem Smeenk, Roberta Allgayer de Moraes, Sabine Bélard, Carlos Lamsfus Calle, Tamirat Gebru Woldearegai, Diane Egger-Adam, Verena Haug, Carina Metz, Alena Reguzova, Markus W. Löffler, Baiba Balode, Lars C. Matthies, Michael Ramharter, Ralf Amann, Peter G. Kremsner

Get full text